VEGF and vascular changes in chronic neuroinflammation

Journal of Autoimmunity

Volumn 21, Issue 4, 2003, Pages 353-363

  Kirk, S L ^a   Karlik, S J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Angiogenesis; EAE; Multiple sclerosis; VEGF

Indexed keywords

VASCULOTROPIN;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CHRONICITY; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; FEMALE; GUINEA PIG; HISTOPATHOLOGY; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPECIES COMPARISON; SPINAL CORD; TEMPORAL ARTERY;

EID: 0242574486     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(03)00139-2     Document Type: Article

References (43)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:(1):1995;27-31.
2. Stromblad S., Cheresh D.A. Integrins, angiogenesis and vascular cell survival. Chem Biol. 3:(11):1996;881-885.
3. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J. 11:1997;457-465.
4. Putnam T.J. Studies in multiple sclerosis: "encephalitis" and sclerotic plaques produced by venular obstruction. Arch Neurol Psychiat (Chic). 33:1935;929-940.
5. Putnam T.J. Evidence of vascular occlusion in multiple sclerosis and "encephalomyelitis" Arch Neurol Psychiat (Chic). 37:1937;1298-1321.
6. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med. 28:2000;938-952.
7. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 47:(6):2000;707-717.
8. Ludwin S.K. The neuropathology of multiple sclerosis. Neuroimaging Clin N Am. 10:2000;625-648.
9. Rindfleisch E. Pathological histology: an introduction to the study of pathological anatomy. Translated from the German by Kloman WC and Miles FT. London: Trubner and Co.; 1872, p. 652-658.
10. Kristensson K., Wisniewski H.M. Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes. Acta Neuropathol (Berl). 39:(3):1977;189-194.
11. Kwon E.E., Prineas J.W. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol. 53:(6):1994;625-636.
12. Adams C. Vascular aspects of multiple sclerosis. A color atlas of multiple sclerosis & other myelin disorders. 1989;184-201 Wolfe Medical Publications, Ltd, UK.
13. Tan I.L., van Schijndel R.A., Pouwels P.J., van Walderveen M.A., Reichenbach J.R., Manoliu R.A., et al. MR Venography of multiple sclerosis. AJNR Am J Neuroradiol. 21:(6):2000;1039-1042.
14. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med. 75:1997;165-173.
15. Dines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol. 56:1997;627-640.
16. Van Meir E.G. Cytokines and tumors of the central nervous system. Glia. 15:1995;264-288.
17. Brod S.A., Kerman R.H., Nelson L.D., Marshall G.D. Jr, Henninger E.M., Khan M., et al. Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis. Mult Scler. 3:1997;1-7.
18. Giovannoni G., Miller D.H., Losseff N.A., Sailer M., Lewellyn-Smith N., Thompson A.J., et al. Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol. 248:2001;487-495.
19. Ziche M., Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol. 50:2000;139-148.
20. Haufschild T., Shaw S.G., Kesselring J., Flammer J. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol. 21:2001;37-38.
21. Salani D., Taraboletti G., Rosano L., Di Castro V., Borsotti P., Giavazzi R., et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 57:2000;1703-1711.
22. Shin T., Kang B., Tanuma N., Matsumoto Y., Wie M., Ahn M., et al. Intrathecal administration of endothelin-1 receptor antagonist ameliorates autoimmune encephalomyelitis in Lewis rats. Neuroreport. 12:2001;1465-1468.
23. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol. 61:(10):2002;914-925.
24. Hiehle J.F., Grossman R.I., Ramer K.N., Gonzalez-Scarano F., Cohen J.A. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. A J N R. 16:1995;69-77.
25. He J., Grossman R.I., Ge Y., Mannon L.J. Enhancing patterns in multiple sclerosis: evolution and persistence. A J N R. 22:2001;649-664.
26. Gill M., Miller S.L., Evans D., Scatliff J.H., Meyerand M.E., Powers S.K., et al. Magnetic resonance imaging and spectroscopy of small ring-enhancing lesions using a rat glioma model. Invest Radiol. 29:1994;301-306.
27. Rashid W., Parkes L.M., Ingle G.T., Chard D.T., Symms M., Tofts P.S., et al. Comparative investigation of cerebral perfusion in multiple sclerosis using a novel technique. 2002;ECTRIMS, Baltimore (USA).
28. Hyduk S.J., Karlik S.J. Apoptotic cells are present in the CNS throughout acute and chronic-progressive EAE in the absence of clinical recovery. J Neuropathol Exp Neurol. 57:1998;602-614.
29. Sehested M., Hou-Jensen K. Factor VII related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch A Pathol Anat Histol. 391:1981;217-225.
30. Toi M., Kashitani J., Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer. 55:1993;371-374.
31. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 36:1995;169-180.
32. Weidner N. Factor VIII related antigen. J Natl Cancer Inst. 85:1993;674-675.
33. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:(1):1991;1-8.
34. Karlik S.J., Strejan G., Gilbert J.J., Noseworthy J.H. NMR studies in experimental allergic encephalomyelitis (EAE): normalization of T1 and T2 with parenchymal cellular infiltration. Neurology. 36:(8):1986;1112-1114.
35. Karlik S.J., Grant E.A., Lee D., Noseworthy J.H. Gadolinium enhancement in acute and chronic-progressive experimentalallergic encephalomyelitis in the guinea pig. Magn Reson Med. 30:(3):1993;326-331.
36. Piraino P.S., Yednock T.A., Freedman S.B., Messersmith E.K., Pleiss M.A., Vandervelt C., et al. Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin. J Neuroimmunol. 131:(1-2):2002;147-159.
37. Winkler J.D., Jackson J.R. Chronic inflammation and angiogenesis. Rubanyi G.M. Angiogenesis in health and disease: basic mechanisms and clinical applications. 2000;407-416 Marcel Dekker, Inc, New York.
38. Folkman J., Brem H. Angiogenesis and inflammation. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation: basic principles and clinical correlates. 2nd edn:1992;821-839 Raven Press, New York.
39. Sobel R.A., Blanchette B.W., Bhan A.K., Colvin R.B. The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J Immunol. 132:(5):1984;2402-2407.
40. Gareau P.J., Rutt B.K., Karlik S.J., Mitchell J.R. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging. 11:2000;586-595.
41. Allen I.V., McQuaid S., Mirakhur M., Nevin G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci. 22:2001;141-144.
42. Dvorak H.F. VPF/VEGF and the angiogenic response. Semin Perinatol. 24:(1):2000;75-78.
43. Griffioen A.W., Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev. 52:2001;237-268.